Results per Page:
TEC specs: tumor endothelial cells in renal cell carcinoma
From the Akilesh Lab, UW Department of Laboratory Medicine & Pathology in collaboration with the Warren Lab, Translational Science and Therapeutics and Dr. Scott Tykodi, a clinical specialist for kidney cancer in the Clinical Research Division
TIME and space predict response to CAR T-cell therapy in lymphoma
From the Hirayama and Turtle labs, Clinical Research Division
Two cans and a string: cancer cells can communicate with neighboring cells
From Dr. Bo Tu, Clinical Research Division
CAF-like cells remodel the Ewing sarcoma tumor microenvironment
From the Lawlor lab, Seattle Children’s Hospital and the Cancer Basic Biology Program of the Cancer Consortium
Improving immunotherapy for advanced prostate cancer
Preclinical work identifies better target and recruits more immune cells to make CAR-T therapy work for solid tumors
Untangling how body location promotes cancer
Beronja Lab postdoc Rachel Lex receives ACS fellowship to uncover regional factors driving tumor development
The ins and outs of the tumor microbiome
From the Bullman Lab, Human Biology Division and Johnston Lab, Vaccine and Infectious Disease Division
Astrocytes prevent tumor cell metastasis in the brain
From the Ghajar Lab, from the Public Health Sciences and Human Biology Divisions
5 questions with a cancer immunotherapy expert
Dr. Phil Greenberg to receive high honor for his contributions to the field
Nanoparticles open doors to cancer-fighting CAR T cells
Tiny liposome-based drug carriers make tumors more vulnerable to targeted immunotherapy
The hidden function of anti-tumoral drug Motolimod to target immunosuppressive cells
from Dr. Nora Disis, Clinical Research Division
Good News: 8 Fred Hutch/UW researchers receive pilot awards
Celebrating faculty and staff achievements